Tevogen Bio Holdings Inc. (TVGN)
NASDAQ: TVGN · Real-Time Price · USD
0.8793
-0.0107 (-1.20%)
At close: Sep 4, 2025, 4:00 PM
0.8700
-0.0093 (-1.06%)
After-hours: Sep 4, 2025, 5:53 PM EDT
Tevogen Bio Holdings Employees
Tevogen Bio Holdings had 18 employees as of December 31, 2024.
Employees
18
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,747,994
Market Cap
172.96M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 18 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
TVGN News
- 1 day ago - Tevogen Underscores the Importance of Precision Immunotherapies, Including TVGN 489 for Vulnerable Individuals Infected with SARS-CoV-2 - GlobeNewsWire
- 8 days ago - Tevogen Bio Highlights Proprietary Assets and Upcoming Valuation Disclosure - GlobeNewsWire
- 9 days ago - Tevogen Expresses Gratitude to Yale for Recognition of Dr. Ryan Saadi and Company's Mission of Health Equity - GlobeNewsWire
- 10 days ago - Tevogen Sees Continued Growth in Institutional Ownership in Q2 2025; 72% of Holders Increased or Maintained Positions - GlobeNewsWire
- 13 days ago - Tevogen Recognized in BINJE's BEST Health Care 2025 for Advancing Health Equity and Sustainable Biopharma - GlobeNewsWire
- 16 days ago - REPEAT -- Tevogen Bio Enters Into Agreement for Up to $50 Million in Financing to Advance R&D and Clinical Development Efforts - GlobeNewsWire
- 16 days ago - Tevogen Delivers Stronger Second Quarter and First Half 2025 Financial Results with Reduced Expenses and Growth Momentum - GlobeNewsWire
- 17 days ago - Tevogen CEO Donates Personal Shares to Support Local Law Enforcement - GlobeNewsWire